Figure 6.
Total ghrelin and ghrelin (AG)-to-des-acyl ghrelin (DAG) ratio in plasma and comorbidities. In (A), the percentage of patients displaying comorbidities is reported. In (B), the prevalence of each type of comorbidity in the examined cohort of patients is represented in percentage. In comparison to children without comorbidities, the total ghrelin plasma levels and AG-to-DAG ratio were not significantly changed in children with newly diagnosed epilepsy, displaying comorbidities (C,D).